Description

Gliclada Tablets with Prolonged Release 60 mg. №30

Ingredients:

Each tablet contains 60 mg of Gliclazide.

Dosage:

The usual dose is one tablet daily, preferably taken with breakfast.

Indications:

Gliclada tablets are indicated for the treatment of type 2 diabetes mellitus. It helps control blood sugar levels and prevent complications associated with diabetes.

Contraindications:

Do not use Gliclada tablets if you have type 1 diabetes, diabetic ketoacidosis, severe kidney or liver problems, or a history of allergic reactions to sulfonylureas.

Directions:

Swallow the tablet whole with a glass of water. Do not crush or chew the tablet. Follow the dosage instructions provided by your healthcare provider.

Scientific Evidence:

Gliclada tablets with prolonged release 60 mg have shown efficacy in lowering blood glucose levels in patients with type 2 diabetes. Studies have demonstrated its ability to stimulate insulin secretion and improve insulin sensitivity, leading to better glycemic control.

Clinical trials have also highlighted the safety and tolerability of Gliclada tablets, making it a valuable option in the management of diabetes. Its prolonged-release formulation offers consistent drug levels, reducing the risk of hypoglycemia.

Additional Information:

• Store Gliclada tablets in a cool, dry place away from direct sunlight.
• Keep out of reach of children and pets.